75 related articles for article (PubMed ID: 19217506)
1. Immunotherapy in Esophagogastric Cancer: Treatment Landscape, Challenges, and New Directions.
Balmaceda NB; Kim SS
J Gastrointest Cancer; 2024 Mar; 55(1):153-167. PubMed ID: 38127239
[TBL] [Abstract][Full Text] [Related]
2. Best Practices for Managing Patients with Unresectable Metastatic Gastric and Gastroesophageal Junction Cancer in Canada.
Snow S; Gabrielson D; Lim H; Tehfe M; Brezden-Masley C
Curr Oncol; 2024 Apr; 31(5):2552-2565. PubMed ID: 38785472
[TBL] [Abstract][Full Text] [Related]
3. Letter to the Editor: Comment on: Role of the Microbiome in the Diagnosis and Management of Gastroesophageal Cancers.
Kountouras J; Kazakos E; Polyzos SA; Zavos C
J Gastrointest Cancer; 2024 Jun; 55(2):679-680. PubMed ID: 38587610
[No Abstract] [Full Text] [Related]
4. Editorial: Comparisons of COVID-19-related disturbance in diagnosis of esophagogastric cancer between the Netherlands and Japan.
Iijima K; Watanabe K; Shimodaira Y
J Gastroenterol; 2024 Jan; 59(1):79-80. PubMed ID: 37971582
[No Abstract] [Full Text] [Related]
5. Impairment of Nutritional Status and Quality of Life Following Minimal-Invasive Esophagectomy-A Prospective Cohort Analysis.
Oberhoff G; Schooren L; Vondran F; Kroh A; Koch A; Bednarsch J; Neumann UP; Schmitz SM; Alizai PH
Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38254757
[TBL] [Abstract][Full Text] [Related]
6. Research Progress of Autofluorescence Imaging Technology in the Diagnosis of Early Gastrointestinal Tumors.
Bi Y; Min M; Cui Y; Xu Y; Li X
Cancer Control; 2021; 28():10732748211044337. PubMed ID: 34569317
[TBL] [Abstract][Full Text] [Related]
7. Robotic transthoracic esophagectomy.
Puntambekar S; Kenawadekar R; Kumar S; Joshi S; Agarwal G; Reddy S; Mallik J
BMC Surg; 2015 Apr; 15():47. PubMed ID: 25898903
[TBL] [Abstract][Full Text] [Related]
8. Do Clinical and Demographic Features of Patients with Upper-Gastrointestinal Cancer Affect their Health-related Quality of Life?
Esmaili-Hesari RA; Homai-Shandiz F; Motevallian A; Madjd Z; Solaymani-Dodaran M; Asadi-Lari M
Int J Prev Med; 2012 Nov; 3(11):783-90. PubMed ID: 23189230
[TBL] [Abstract][Full Text] [Related]
9. [Clinical and pathological prognostic factors for cancers of the esophagogastric junction].
Schmidt SC; Schlechtweg N; Veltzke-Schlieker W; Thuss-Patience P; Pratschke J; Neuhaus P; Schumacher G
Zentralbl Chir; 2009 Sep; 134(5):455-61. PubMed ID: 19757346
[TBL] [Abstract][Full Text] [Related]
10. Tumors of the esophagus, gastroesophageal junction, and stomach.
Sweed MR; Edmonson D; Cohen SJ
Semin Oncol Nurs; 2009 Feb; 25(1):61-75. PubMed ID: 19217506
[TBL] [Abstract][Full Text] [Related]
11. Cancers of the pancreas and hepatobiliary system.
Sauerland C; Engelking C; Wickham R; Pearlstone DB
Semin Oncol Nurs; 2009 Feb; 25(1):76-92. PubMed ID: 19217507
[TBL] [Abstract][Full Text] [Related]
12. Colon, rectal, and anal cancers.
Wilkes G; Hartshorn K
Semin Oncol Nurs; 2009 Feb; 25(1):32-47. PubMed ID: 19217504
[TBL] [Abstract][Full Text] [Related]
13. Adenocarcinoma of the esophagus and cardia: a review of the disease and its treatment.
DeMeester SR
Ann Surg Oncol; 2006 Jan; 13(1):12-30. PubMed ID: 16378161
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors in adenocarcinoma of the esophagus or gastroesophageal junction.
Lagarde SM; ten Kate FJ; Reitsma JB; Busch OR; van Lanschot JJ
J Clin Oncol; 2006 Sep; 24(26):4347-55. PubMed ID: 16963732
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
